IBDEI0T5 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13115,1,3,0)
 ;;=3^Corneal Ectasia,OD
 ;;^UTILITY(U,$J,358.3,13115,1,4,0)
 ;;=4^H18.711
 ;;^UTILITY(U,$J,358.3,13115,2)
 ;;=^5005102
 ;;^UTILITY(U,$J,358.3,13116,0)
 ;;=H18.20^^51^629^20
 ;;^UTILITY(U,$J,358.3,13116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13116,1,3,0)
 ;;=3^Corneal Edema,Unspec
 ;;^UTILITY(U,$J,358.3,13116,1,4,0)
 ;;=4^H18.20
 ;;^UTILITY(U,$J,358.3,13116,2)
 ;;=^5005035
 ;;^UTILITY(U,$J,358.3,13117,0)
 ;;=H16.403^^51^629^23
 ;;^UTILITY(U,$J,358.3,13117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13117,1,3,0)
 ;;=3^Corneal Neovascularization,OU,Unspec
 ;;^UTILITY(U,$J,358.3,13117,1,4,0)
 ;;=4^H16.403
 ;;^UTILITY(U,$J,358.3,13117,2)
 ;;=^5004967
 ;;^UTILITY(U,$J,358.3,13118,0)
 ;;=H16.401^^51^629^21
 ;;^UTILITY(U,$J,358.3,13118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13118,1,3,0)
 ;;=3^Corneal Neovascularization,OD,Unspec
 ;;^UTILITY(U,$J,358.3,13118,1,4,0)
 ;;=4^H16.401
 ;;^UTILITY(U,$J,358.3,13118,2)
 ;;=^5004965
 ;;^UTILITY(U,$J,358.3,13119,0)
 ;;=H16.402^^51^629^22
 ;;^UTILITY(U,$J,358.3,13119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13119,1,3,0)
 ;;=3^Corneal Neovascularization,OS,Unspec
 ;;^UTILITY(U,$J,358.3,13119,1,4,0)
 ;;=4^H16.402
 ;;^UTILITY(U,$J,358.3,13119,2)
 ;;=^5004966
 ;;^UTILITY(U,$J,358.3,13120,0)
 ;;=H21.242^^51^629^26
 ;;^UTILITY(U,$J,358.3,13120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13120,1,3,0)
 ;;=3^Degen of Pupillary Margin,OS
 ;;^UTILITY(U,$J,358.3,13120,1,4,0)
 ;;=4^H21.242
 ;;^UTILITY(U,$J,358.3,13120,2)
 ;;=^5005192
 ;;^UTILITY(U,$J,358.3,13121,0)
 ;;=H21.241^^51^629^25
 ;;^UTILITY(U,$J,358.3,13121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13121,1,3,0)
 ;;=3^Degen of Pupillary Margin,OD
 ;;^UTILITY(U,$J,358.3,13121,1,4,0)
 ;;=4^H21.241
 ;;^UTILITY(U,$J,358.3,13121,2)
 ;;=^5005191
 ;;^UTILITY(U,$J,358.3,13122,0)
 ;;=H18.9^^51^629^13
 ;;^UTILITY(U,$J,358.3,13122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13122,1,3,0)
 ;;=3^Cornea Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,13122,1,4,0)
 ;;=4^H18.9
 ;;^UTILITY(U,$J,358.3,13122,2)
 ;;=^5005132
 ;;^UTILITY(U,$J,358.3,13123,0)
 ;;=H16.213^^51^629^32
 ;;^UTILITY(U,$J,358.3,13123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13123,1,3,0)
 ;;=3^Exposure Keratoconjunctivitis,OU
 ;;^UTILITY(U,$J,358.3,13123,1,4,0)
 ;;=4^H16.213
 ;;^UTILITY(U,$J,358.3,13123,2)
 ;;=^5004922
 ;;^UTILITY(U,$J,358.3,13124,0)
 ;;=H16.211^^51^629^30
 ;;^UTILITY(U,$J,358.3,13124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13124,1,3,0)
 ;;=3^Exposure Keratoconjunctivitis,OD
 ;;^UTILITY(U,$J,358.3,13124,1,4,0)
 ;;=4^H16.211
 ;;^UTILITY(U,$J,358.3,13124,2)
 ;;=^5004920
 ;;^UTILITY(U,$J,358.3,13125,0)
 ;;=H16.212^^51^629^31
 ;;^UTILITY(U,$J,358.3,13125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13125,1,3,0)
 ;;=3^Exposure Keratoconjunctivitis,OS
 ;;^UTILITY(U,$J,358.3,13125,1,4,0)
 ;;=4^H16.212
 ;;^UTILITY(U,$J,358.3,13125,2)
 ;;=^5004921
 ;;^UTILITY(U,$J,358.3,13126,0)
 ;;=H21.81^^51^629^33
 ;;^UTILITY(U,$J,358.3,13126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13126,1,3,0)
 ;;=3^Floppy Iris Syndrome
 ;;^UTILITY(U,$J,358.3,13126,1,4,0)
 ;;=4^H21.81
 ;;^UTILITY(U,$J,358.3,13126,2)
 ;;=^5005263
 ;;^UTILITY(U,$J,358.3,13127,0)
 ;;=H20.812^^51^629^35
 ;;^UTILITY(U,$J,358.3,13127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13127,1,3,0)
 ;;=3^Fuchs' Heterochromic Cyclitis,OS
 ;;^UTILITY(U,$J,358.3,13127,1,4,0)
 ;;=4^H20.812
